Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Outcome measures in psoriatic arthritis: Where next?
Simon Hackett, Laura C. Coates
Musculoskeletal Care (2022) Vol. 20, Iss. S1
Open Access | Times Cited: 13

Showing 13 citing articles:

Psoriatic arthritis in Jordan: a cross-sectional study of disease characteristics, patient-reported outcomes, and disease activity
Fatima Alnaimat, Khaldoon Alawneh, Ayman AbuHelal, et al.
BMC Rheumatology (2025) Vol. 9, Iss. 1
Open Access
Efficacy and safety of izokibep in patients with active psoriatic arthritis: a randomised, double-blind, placebo-controlled, phase 2 study
Peter C. Taylor, Philip J. Mease, Kurt de Vlam, et al.
Annals of the Rheumatic Diseases (2025)
Open Access
Impact of Central Sensitization on Clinical and Functional Aspects of Psoriatic Arthritis
Mehmet Nur Kaya, Duygu Tecer, Özlem Kılıç, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1449-1449
Open Access | Times Cited: 1
Management of psoriatic arthritis: a consensus opinion by expert rheumatologists
Salvatore D’Angelo, Fabiola Atzeni, Maurizio Benucci, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study
Alberto Lo Gullo, Andrea Becciolini, Simone Parisi, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 12, pp. 3892-3892
Open Access | Times Cited: 1
Autoimmune thyroiditis in psoriatic disease
Lamiaa E. Elghandour, Amal M El Ganzoury, Neven Fouda, et al.
Romanian Journal of Rheumatology (2024) Vol. 33, Iss. 1, pp. 39-47
Open Access
Interleukin 17 as a central component of the pathogenesis of pain associated with immunoinflammatory process: A new “target” of pharmacotherapy
А. Е. Каратеев, Е. Yu. Polishchuk, Т. В. Дубинина
Rheumatology Science and Practice (2024) Vol. 62, Iss. 2, pp. 154-161
Open Access
Evaluation of CD4+ CD25+/high CD127low/- Regulatory T-Cells in Different Stages of Psoriatic Arthritis Patients
Roya Safari, Abdolhussein Shakurnia, Ata Ghadiri, et al.
Advanced Biomedical Research (2024) Vol. 13, Iss. 1
Open Access
Factors predicting treatment response to biological and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis – a systematic review and meta-analysis
T. Künzler, Monika Bamert, Haiko Sprott
Clinical Rheumatology (2024)
Open Access
The impact of psoriatic arthritis on quality of life: a systematic review
Lija James, Louise Hailey, Rhea Suribhatla, et al.
Therapeutic Advances in Musculoskeletal Disease (2024) Vol. 16
Open Access
Morus alba extract suppresses IL-17-induced abnormal proliferation in 3D-reconstructed epidermis
Takahiro Oyama, Michiru Usui, Ena Sato, et al.
Phytomedicine Plus (2023) Vol. 3, Iss. 2, pp. 100455-100455
Open Access
Comparative Efficacy of Targeted Therapies in Treating Multiple Domains of Psoriatic Arthritis - A Single Center Study
D Grishma, S. Rajeswari, C Saranya, et al.
International Journal of Science and Research (IJSR) (2023) Vol. 12, Iss. 12, pp. 339-344
Open Access
Page 1

Scroll to top